GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Related products :

Catalog number Product name Quantity
29-567 Renin catalyzes the first step in the activation pathway of angiotensinogen--a cascade that can result in aldosterone release,vasoconstriction, and increase in blood pressure. Renin, an aspartyl prote 0.1 mg
25-721 Coagulation factor II is proteolytically cleaved to form thrombin in the first step of the coagulation cascade which ultimately results in the stemming of blood loss. F2 also plays a role in maintaini 0.05 mg
29-637 F10 is the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form b 0.05 mg
25-720 F10 is the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form b 0.05 mg
B1090 Kracke Blood Culture Medium USE : For isolating organisms from the blood in bacterimias and for maintaining cultures isolated from blood. 5x500gm
B430 Blood Agar Base w_low pH(w_o Blood) USE After addition of blood medium is used for isolation and cultivation of fastidious organisms. Qty per Litre of Medium: 40
B1090 Kracke Blood Culture Medium USE For isolating organisms from the blood in bacterimias and for maintaining cultures isolated from blood. Qty per Litre of Medium: 75
B430 Blood Agar Base w_low pH(w_o Blood) USE : After addition of blood medium is used for isolation and cultivation of fastidious organisms. 5x500gm
PR-945 Human Factor Xa Serine endoprotease from the coagulation cascade human plasma 10
PR-945 Human Factor Xa Serine endoprotease from the coagulation cascade human plasma 50 µg
PR-945 Human Factor Xa Serine endoprotease from the coagulation cascade human plasma 50µg
25-959 GPR177 has signal transducer activity. It is positive regulation of I-kappaB kinase_NF-kappaB cascade. 0.05 mg
B014 Blood Agar Base (Infusion Agar) w_o Blood USE : For isolation and cultivation of many fastidious pathogenic organisms after addition of blood. 5x500gm
B014 Blood Agar Base (Infusion Agar) w_o Blood USE For isolation and cultivation of many fastidious pathogenic organisms after addition of blood. Qty per Litre of Medium: 40
25-781 The Rh blood group system is the second most clinically significant of the blood groups, second only to ABO. It is also the most polymorphic of the blood groups, with variations due to deletions, gene 0.05 mg
25-185 RCVRN is a member of the recoverin family of neuronal calcium sensors. The protein contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in th 0.05 mg
ABEL-05M3 Cell Activation Test Kits for Whole Blood with Pholasin® & Adjuvant_K™ (microplate format)* No PMA or fMLP, extra blood dilution buffer, blood dilution tubes & caps. _ Volume of test 200 µl 400 tests
26-803 Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for in 0.05 mg
28-817 RCV1 is a member of the recoverin family of neuronal calcium sensors. RCV1 contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in the retina 0.05 mg
orb61099 Sorafenib, p-Toluenesulfonate Salt Sorafenib Tosylate is a novel, small molecular inhibitor of several tyrosine protein kinases (VEGFR and PDGFR) and RAF_MEK_ERK cascade inhibitor with an IC50 of 6, 2 300 mg
orb61100 Sorafenib, Free Base Sorafenib Tosylate is a novel, small molecular inhibitor of several tyrosine protein kinases (VEGFR and PDGFR) and RAF_MEK_ERK cascade inhibitor with an IC50 of 6, 22, 38 nM for R 300 mg
orb61289 Sorafenib (free base) Sorafenib (Nexavar) is a novel, small molecular inhibitor of several tyrosine protein kinases (VEGFR and PDGFR) and RAF_MEK_ERK cascade inhibitor with an IC50 of 6, 22, 38 nM for 100 mg
ABEL-06M Cell Activation Test Kits for Whole Blood with Pholasin® & Adjuvant_K™ (microplate format) No PMA, fMLP or R & A Buffer. Extra Pholasin®, blood dilution buffer, blood dilution tubes & caps. _ Volume o 600 tests
ABEL-05M Cell Activation Test Kits for Whole Blood with Pholasin® & Adjuvant_K™ (microplate format) No PMA, fMLP or R & A Buffer. Extra Pholasin®, blood dilution buffer, blood dilution tubes & caps. _ Volume o 400 tests
ABEL-04M2 Cell Activation Test Kits for Whole Blood with Pholasin® & Adjuvant_K™ (microplate format) No PMA, fMLP or R & A Buffer. Extra Pholasin®, blood dilution buffer, blood dilution tubes & caps. _ Volume o 200-300 tests

Pathways :

WP255: Blood Clotting Cascade
WP775: Blood Clotting Cascade
WP460: Blood Clotting Cascade
WP887: Blood Clotting Cascade
WP1122: Blood Clotting Cascade
WP272: Blood Clotting Cascade
WP1818: Formation of Fibrin Clot (Clotting Cascade)
WP1009: MAPK Cascade
WP778: MAPK Cascade
WP1056: Complement and Coagulation Cascades
WP1343: MAPK Cascade
WP1826: GPVI-mediated activation cascade
WP449: Complement and Coagulation Cascades
WP820: Complement and Coagulation Cascades
WP422: MAPK Cascade
WP892: MAPK Cascade
WP1128: MAPK Cascade
WP2328: Allograft rejection
WP558: Complement and Coagulation Cascades
WP251: MAPK Cascade
WP402: ERK1 - ERK2 MAPK cascade
WP1798: Complement cascade
WP1172: Complement and Coagulation Cascades
WP547: Complement and Coagulation Cascades
WP1844: MAP kinase cascade

Related Genes :
[] Clotting factor G beta subunit (EC 3.4.21.85) [Cleaved into: Clotting factor G beta subunit light chain; Clotting factor G beta subunit heavy chain]
[] Thrombin-like enzyme kangshuanmei (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[] Thrombin-like enzyme leucurobin (Leuc) (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[] Clotting factor C (FC) (EC 3.4.21.84) (Limulus factor C) [Cleaved into: Clotting factor C heavy chain; Clotting factor C light chain; Clotting factor C chain A; Clotting factor C chain B]
[] Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]
[] Thrombin-like enzyme TLBan (SVTLE TLBan) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragments)
[] Thrombin-like enzyme stejnobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[] Thrombin-like enzyme BjussuSP-1 (SVTLE BjussuSP-1) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Jararacussin-I) (Snake venom serine protease 1) (SVSP) (Thrombin-like enzyme BjussuSP-I) (SVTLE BjussuSP-I)
[] Thrombin-like enzyme acutobin-2 (SVTLE) (EC 3.4.21.-) (Acutobin II) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Thrombin-like enzyme bhalternin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[] Thrombin-like enzyme BpirSP27 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Thrombin-like enzyme bothrombin (SVTLE) (EC 3.4.21.74) (Factor VIII activator) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A)
[] Thrombin-like enzyme BpirSP41 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Clotting factor G alpha subunit (EC 3.2.1.-)
[] Thrombin-like enzyme crotalase (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease 2) (SVSP)
[] Thrombin-like enzyme TLBm (SVTLE TLBm) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[SEMA7A CD108 SEMAL] Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108)
[] Thrombin-like enzyme jerdonobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Thrombin-like enzyme elegaxobin-1 (SVTLE) (EC 3.4.21.-) (Elegaxobin I) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[] Limulus clotting factor C (FC) (EC 3.4.21.84) [Cleaved into: Limulus clotting factor C heavy chain; Limulus clotting factor C light chain; Limulus clotting factor C chain A; Limulus clotting factor C chain B]
[] Thrombin-like enzyme purpurase (SVTLE purpurase) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Thrombin-like enzyme cerastocytin (SVTLE) (EC 3.4.21.-) (C.cerastes platelet proaggregant protein) (CC-PPP) (Factor VIII activator) (Fibrinogen-clotting enzyme) (Proaggregant serine proteinase) (Snake venom serine protease) (SVSP)
[] Thrombin-like enzyme asperase (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[] Thrombin-like enzyme batroxobin (BX) (SVTLE) (EC 3.4.21.74) (Bothrops atrox serine proteinase) (Defibrase) (Fibrinogen-clotting enzyme) (Reptilase) (Snake venom serine protease) (SVSP) (Venombin A)
[] Thrombin-like enzyme D-V (SVTLE D-V) (EC 3.4.21.-) (Clotting factor) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Thrombin-like enzyme BJ-48 (SVTLE BJ-48) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[] Thrombin-like enzyme calobin-2 (SVTLE) (EC 3.4.21.-) (Calobin II) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[Abo2] Histo-blood group ABO system transferase 2 (B blood group galactosyltransferase) (Blood group A glycosyltransferase 2) (Cis-AB transferase 2) (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (NAGAT 2) (Putative blood group A transferase T2)
[Abo Abo1] Histo-blood group ABO system transferase 1 (Blood group A glycosyltransferase 1) (Cis-AB transferase 1) (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (N-acetylgalactosaminyltransferase A blood group-like enzyme) (NAGAT 1)
[] Thrombin-like enzyme BpSP-1 (SVTLE BpSP-1) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Thrombin-like enzyme BpSP-I) (SVTLE BpSP-I) (Fragment)

Bibliography :
[34611926] Elevation of circulating neutrophil extracellular traps, interleukin (IL)-8, IL-22, and vascular endothelial growth factor in patients with venomous snake mamushi (Gloydius blomhoffii) bites.
[34611839] Tranexamic acid use is associated with reduced intraoperative blood loss during spine surgery for Marfan syndrome.
[34602515] [Molecular Mechanisms Underlying Cellular Responses to the Loading of Non-thermal Atmospheric Pressure Plasma-activated Solutions].
[34578700] Detection of Circulating Serum Protein Biomarkers of Non-Muscle Invasive Bladder Cancer after Protein Corona-Silver Nanoparticles Analysis by SWATH-MS.
[34575869] High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies.
[34572916] Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21).
[34564628] The Influence of Zearalenone on Selected Hemostatic Parameters in Sexually Immature Gilts.
[34522848] .
[34521332] Direct (new) oral anticoagulants (DOACs): Drawbacks, bleeding and reversal.
[34511578] Coagulation, Protease-Activated Receptors, and Diabetic Kidney Disease: Lessons from eNOS-Deficient Mice.